Загрузка...
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1
Fibroblast growth factor-23 (FGF23) is a phosphaturic hormone that contributes to several hypophosphatemic disorders by reducing the expression of the type II sodium-phosphate cotransporters (NaPi-2a and NaPi-2c) in the kidney proximal tubule and by reducing serum 1,25-dihydroxyvitamin D(3) [1,25(OH...
Сохранить в:
Главные авторы: | , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
American Physiological Society
2009
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2724258/ https://ncbi.nlm.nih.gov/pubmed/19515808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.90742.2008 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|